Home Spirometer Market Size Analysis and Top Companies
The global home spirometermarket size is estimated to hit around USD 1.68 billion by 2033, increasing from USD 1.17 billion in 2023 with a CAGR of 3.70% from 2023 to 2033. The top companies operating in the home spirometer are Vitalograph Ltd., MIR (Medical International Research), Schiller AG, Nihon Kohden Corporation, NDD Medical Technologies, Contec Medical Systems Co., Ltd., Microlife Corporation, Fysiomed, CareFusion Corporation (acquired by BD), SDI Diagnostics, Cosmed, Jones Medical Instrument Company, Bionet America, Inc., Futuremed America Inc., Medtronic plc, and Others.
Market Report Coverage
| Report Coverage |
Details |
| Market Size in 2023 |
USD 1.17 Billion |
| Market Size in 2024 |
USD 1.21 Billion |
| Market Size by 2033 |
USD 1.68 Billion |
| Growth Rate from 2024 to 2033 |
CAGR of 3.70% |
| Largest Market |
North America |
| Base Year |
2023 |
| Forecast Period |
2024 to 2033 |
| Segments Covered |
Type, Technology, Application, End User, and Region |
| Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Home Spirometer Key Players
- Vitalograph Ltd.
- MIR (Medical International Research)
- Schiller AG
- Nihon Kohden Corporation
- NDD Medical Technologies
- Contec Medical Systems Co., Ltd.
- Microlife Corporation
- Fysiomed
- CareFusion Corporation (acquired by BD)
- SDI Diagnostics
- Cosmed
- Jones Medical Instrument Company
- Bionet America, Inc.
- Futuremed America Inc.
- Medtronic plc
Recent Developments
- In 2018, Schiller AG expanded its global presence by inaugurating a new manufacturing facility in Guangzhou, China, showcasing the company's commitment to meeting the increasing demand for medical devices in the Asian market.
- In the same year, Schiller AG demonstrated its commitment to innovation by introducing the CARDIOVIT CS-200 ErgoSpiro System device in November. This device likely aimed to provide advanced cardiovascular and respiratory monitoring capabilities, contributing to Schiller AG's portfolio of cutting-edge medical equipment.
- In 2017, MIR, a medical device company, collaborated with Tactio Health Group based in Canada to pioneer telemedicine solutions specifically designed for Chronic Obstructive Pulmonary Disease (COPD). This strategic partnership aimed to leverage technology for remote monitoring and management of COPD, aligning with the broader trend of incorporating digital health solutions into respiratory care.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
